Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nicotine vaping products versus varenicline for smoking cessation in socioeconomically disadvantaged adults
ACTRN12625000179437Phase 3Active, not recruiting
- Sponsor
- University of New South Wales
- Start
- Sep 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in nicotine dependence comparing Nicotine vaping products with Varenicline (2 arms). Primary endpoint: Carbon monoxide verified 6-month continuous abstinence. Started Sep 2025; status: active, not recruiting.
02
Drugs
vareniclinenicotine
03
Conditions
nicotine dependence
Beyond the preview
Go deeper on ACTRN12625000179437.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12625000179437.